Shareholder's Equity (Details) - USD ($)				1 Months Ended			3 Months Ended
	Mar. 17, 2020	Jan. 13, 2020	Dec. 11, 2019	Apr. 30, 2020	Mar. 26, 2020	Aug. 19, 2018	Jun. 30, 2020	Mar. 25, 2020	Dec. 31, 2019
Shareholder's Equity (Details) [Line Items]
Aggregate of shares Issued						1,275,000
Warrants to purchase shares						1,170,000
Private placement of gross proceeds (in Dollars)						$ 2,550,000
Warrants Exercise price (in Dollars per share)						$ 2.25
Number of expire year						5 years
Purchase price per share (in Dollars per share)									$ 2.00
Description of warrants							a) indexed to its own stock; and b) classified in stockholders’ equity. The warrants were recorded at their fair value on the date of grant as a component of stockholders’ equity. On June 5, 2019, the Company agreed to issue to the Holders an aggregate of 1,170,000 shares (“Exchange Shares”) of the Company’s common stock, par value $0.0001 per share and warrant to purchase an aggregate of 1,170,000 shares of Common Stock (the “Exchange Warrants”) as the negotiated purchase price for the Existing Warrants based on the Black Scholes Value as a result of a certain transaction which was deemed as a Fundamental Transaction as defined in purchase agreement. On March 23, 2020, 585,000 warrants has been cashless exercised to 287,049 shares of common stock.
Preferred stock convert into common stock					1,000
Common stock convert into preferred stock					1,000
Liquidation, description		In the event of the liquidation of the Company, the Preferred Stock has a preference equal to $3,500,000 over the Company’s common stock.
Purchase of common stock								1,783,167
Common stock exchange amount (in Dollars)								$ 2,500,000
Shares for acquisition	900,000
DL Medical [Member]
Shareholder's Equity (Details) [Line Items]
percentage of noncontrolling interest				30.00%
Conversion Agreement [Member]
Shareholder's Equity (Details) [Line Items]
Preferred stock convert into common stock			1,000
Common stock convert into preferred stock			1,000
Conversion Agreement [Member]
Shareholder's Equity (Details) [Line Items]
Contribution (in Dollars)		$ 3,500,000
Preferrd shares converted		1,000
Common stock converted (in Dollars per share)		$ 9,210,526
Common Stock [Member]
Shareholder's Equity (Details) [Line Items]
Shares issues				3,852,372			4,752,372
Shares for acquisition				3,834,796
Series B Preferred Stock [Member]
Shareholder's Equity (Details) [Line Items]
Preferrd shares converted				1,000